TB-500 Research Peptide | Lab Tested | PrecisionsPeptides.com

Catalyst Compounds TB-500 Capsules

Colten — Wed, 17 Jun 2026 23:18:29 +0000

This oral capsule format delivers TB-500, a synthetic fragment of the actin-binding protein thymosin beta-4, in a research-convenient solid-dose preparation. Researchers use it to examine cytoskeletal regulation and cell migration.

Investigations span angiogenesis, cellular motility, extracellular matrix turnover, and inflammatory modulation in cultured systems and animal models. The encapsulated form supports oral-route study designs and simplified handling in laboratory settings.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds TB-500 Capsules appeared first on PrecisionsPeptides.com.

Catalyst Compounds TB-500 Nasal Spray

Colten — Wed, 17 Jun 2026 23:14:49 +0000

This intranasal preparation delivers TB-500, a synthetic fragment of thymosin beta-4 studied for actin binding and cell migration, in a mucosal-route research format. It supports investigation of regeneration-associated signaling.

Research applications include angiogenesis, cell motility, matrix remodeling, and inflammatory modulation in cell and animal systems. The nasal format supports bioavailability and absorption-route study designs in laboratory settings.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds TB-500 Nasal Spray appeared first on PrecisionsPeptides.com.

Catalyst Compounds TB-500

Colten — Wed, 17 Jun 2026 22:41:34 +0000

TB-500 is a synthetic fragment corresponding to the active region of thymosin beta-4, a naturally occurring actin-sequestering protein. Researchers employ it as a reference compound for examining cytoskeletal dynamics and cellular migration.

Reported laboratory investigations cover angiogenesis, fibroblast and endothelial motility, extracellular matrix turnover, and inflammatory modulation within cultured cells and animal repair models. Its actin-binding behavior

supports mechanistic study of regeneration-associated pathways.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds TB-500 appeared first on PrecisionsPeptides.com.

Real Peptides TB-500

Graham — Wed, 17 Jun 2026 22:14:15 +0000

TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4, a naturally occurring actin-binding protein. It has been characterized in preclinical research as a modulator of actin dynamics and cell migration, making it a useful tool compound for isolating tissue-repair endpoints in experimental designs.

TB-500 has been examined in preclinical in vitro and rodent model studies of cell migration, angiogenesis, extracellular matrix remodeling, inflammatory signaling, and wound-healing dynamics. Its actin-regulating activity supports mechanistic characterization of tissue-repair biology in cell-based and rodent research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides TB-500 appeared first on PrecisionsPeptides.com.

Groov Bioscience TB-500

Colten — Mon, 08 Jun 2026 19:59:13 +0000

TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring actin-binding protein. Researchers use it as a probe of cytoskeletal behavior and cell movement.

In cultured cells and laboratory animals, work has focused on vessel growth, fibroblast and endothelial motility, matrix turnover, and inflammatory signaling. Its actin-binding action supports study of repair-related pathways.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Groov Bioscience TB-500 appeared first on PrecisionsPeptides.com.